IL-12p40/IL-10 Producing preCD8α/Clec9A+Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection

PLoS Pathogens

Volumn 12, Issue 4, 2016, Pages

  Torres, David ^a   Köhler, Arnaud ^a   Delbauve, Sandrine ^a   Caminschi, Irina ^b,c   Lahoud, Mireille H ^b,d   Shortman, Ken ^b,c,e   Flamand, Véronique ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD11B ANTIGEN; CD24 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN; CLEC9A ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; CD8 ANTIGEN; CLEC9A PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; LECTIN; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BARE LYMPHOCYTE SYNDROME; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL PROTECTION; CELL SELECTION; CELL TRANSFER; COLONY FORMING UNIT; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNE CELL FUNCTION ASSAY; IMMUNE RESPONSE; IMMUNIZATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; OOCYTE; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DNA MICROARRAY; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; ANTIGEN PRESENTATION; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; IMMUNITY, INNATE; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; LECTINS, C-TYPE; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IMMUNOLOGIC; TRANSCRIPTOME;

EID: 84964840369     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005561     Document Type: Article

References (60)

1. Adkins B, Leclerc C, Marshall-Clarke S, Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004;4(7):553–64. 15229474.
2. Lee HH, Hoeman CM, Hardaway JC, Guloglu FB, Ellis JS, Jain R, et al. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med. 2008;205(10):2269–80. 18762566. doi: 10.1084/jem.20071371
3. Vazquez-Boland JA, Kuhn M, Berche P, Chakraborty T, Dominguez-Bernal G, Goebel W, et al. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev. 2001;14(3):584–640. 11432815.
4. Poulin LF, Reyal Y, Uronen-Hansson H, Schraml BU, Sancho D, Murphy KM, et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood. 2012;119(25):6052–62. 22442345. doi: 10.1182/blood-2012-01-406967
5. Aliberti J, Schulz O, Pennington DJ, Tsujimura H, Reis e Sousa C, Ozato K, et al. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood. 2003;101(1):305–10. 12393690.
6. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science. 2008;322(5904):1097–100. 19008445. doi: 10.1126/science.1164206
7. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nature immunology. 2003;4(4):380–6. 12598895.
8. Kashiwada M, Pham NL, Pewe LL, Harty JT, Rothman PB, NFIL3/E4BP4 is a key transcription factor for CD8alpha(+) dendritic cell development. Blood. 2011;117(23):6193–7. 21474667. doi: 10.1182/blood-2010-07-295873
9. Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med. 2002;195(10):1289–302. 12021309.
10. den Haan JM, Bevan MJ, Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med. 2002;196(6):817–27. 12235214.
11. den Haan JM, Lehar SM, Bevan MJ, CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med. 2000;192(12):1685–96. 11120766.
12. Pooley JL, Heath WR, Shortman K, Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol. 2001;166(9):5327–30. 11313367.
13. Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, El-Sukkari D, et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A. 2006;103(28):10729–34. 16807294.
14. Schulz O, Reis e Sousa C, Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology. 2002;107(2):183–9. 12383197.
15. Belz GT, Shortman K, Bevan MJ, Heath WR, CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J Immunol. 2005;175(1):196–200. 15972648.
16. Belz GT, Smith CM, Eichner D, Shortman K, Karupiah G, Carbone FR, et al. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol. 2004;172(4):1996–2000. 14764661.
17. Neuenhahn M, Kerksiek KM, Nauerth M, Suhre MH, Schiemann M, Gebhardt FE, et al. CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity. 2006;25(4):619–30. 17027298.
18. Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nature immunology. 2000;1(1):83–7. 10881180.
19. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 1997;186(11):1819–29. 9382881.
20. Reis e Sousa C, Yap G, Schulz O, Rogers N, Schito M, Aliberti J, et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity. 1999;11(5):637–47. 10591188.
21. Steinman RM, Pack M, Inaba K, Dendritic cells in the T-cell areas of lymphoid organs. Immunological reviews. 1997;156:25–37. 9176697.
22. Vollstedt S, Franchini M, Hefti HP, Odermatt B, O'Keeffe M, Alber G, et al. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J Exp Med. 2003;197(5):575–84. 12615899.
23. Sun CM, Fiette L, Tanguy M, Leclerc C, Lo-Man R, Ontogeny and innate properties of neonatal dendritic cells. Blood. 2003;102(2):585–91. 12663436.
24. Ruckwardt TJ, Malloy AM, Morabito KM, Graham BS, Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response. PLoS Pathog. 2014;10(2):e1003934. 24550729. doi: 10.1371/journal.ppat.1003934
25. Hermann E, Truyens C, Alonso-Vega C, Even J, Rodriguez P, Berthe A, et al. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood. 2002;100(6):2153–8. 12200380.
26. Marchant A, Goldman M, T cell-mediated immune responses in human newborns: ready to learn?Clin Exp Immunol. 2005;141(1):10–8. 15958064.
27. Kollmann TR, Reikie B, Blimkie D, Way SS, Hajjar AM, Arispe K, et al. Induction of protective immunity to Listeria monocytogenes in neonates. J Immunol. 2007;178(6):3695–701. 17339467.
28. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996;184(5):1953–62. 8920882.
29. Sathe P, Pooley J, Vremec D, Mintern J, Jin JO, Wu L, et al. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J Immunol. 2011;186(9):5184–92. 21422244. doi: 10.4049/jimmunol.1002683
30. Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 2008;112(8):3264–73. 18669894. doi: 10.1182/blood-2008-05-155176
31. Tagliani E, Guermonprez P, Sepulveda J, Lopez-Bravo M, Ardavin C, Amigorena S, et al. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells. J Immunol. 2008;180(5):3201–9. 18292544.
32. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med. 2004;199(6):815–24. 15024047.
33. Chen Y, Nakane A, Minagawa T, Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice. Infect Immun. 1989;57(8):2345–9. 2501217.
34. Ito S, Ishii KJ, Gursel M, Shirotra H, Ihata A, Klinman DM, CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. J Immunol. 2005;174(2):777–82. 15634898.
35. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity. 2002;17(2):211–20. 12196292.
36. Muraille E, Giannino R, Guirnalda P, Leiner I, Jung S, Pamer EG, et al. Distinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes. Eur J Immunol. 2005;35(5):1463–71. 15816001.
37. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K, CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol. 2000;164(6):2978–86. 10706685.
38. Belz GT, Vremec D, Febbraio M, Corcoran L, Shortman K, Carbone FR, et al. CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo. J Immunol. 2002;168(12):6066–70. 12055215.
39. Anjuere F, Martin P, Ferrero I, Fraga ML, del Hoyo GM, Wright N, et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood. 1999;93(2):590–8. 9885220.
40. Bedoui S, Prato S, Mintern J, Gebhardt T, Zhan Y, Lew AM, et al. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. J Immunol. 2009;182(7):4200–7. 19299718. doi: 10.4049/jimmunol.0802286
41. Goriely S, Vincart B, Stordeur P, Vekemans J, Willems F, Goldman M, et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol. 2001;166(3):2141–6. 11160266.
42. Mattner F, Ozmen L, Podlaski FJ, Wilkinson VL, Presky DH, Gately MK, et al. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock. Infect Immun. 1997;65(11):4734–7. 9353058.
43. Shimozato O, Ugai S, Chiyo M, Takenobu H, Nagakawa H, Wada A, et al. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology. 2006;117(1):22–8. 16423037.
44. Abdi K, IL-12: the role of p40 versus p75. Scand J Immunol. 2002;56(1):1–11. 12100467.
45. Holscher C, Atkinson RA, Arendse B, Brown N, Myburgh E, Alber G, et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol. 2001;167(12):6957–66. 11739515.
46. Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, Pearl JE, et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006;203(7):1805–15. 16818672.
47. Piccotti JR, Chan SY, Li K, Eichwald EJ, Bishop DK, Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells. J Immunol. 1997;158(2):643–8. 8992979.
48. Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol. 1998;160(3):1132–8. 9570526.
49. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ, IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunological reviews. 2004;202:96–105. 15546388.
50. Meeks KD, Sieve AN, Kolls JK, Ghilardi N, Berg RE, IL-23 is required for protection against systemic infection with Listeria monocytogenes. J Immunol. 2009;183(12):8026–34. 19923464. doi: 10.4049/jimmunol.0901588
51. Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM, IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol. 2008;181(12):8576–84. 19050277.
52. Genovese F, Mancuso G, Cuzzola M, Biondo C, Beninati C, Delfino D, et al. Role of IL-10 in a neonatal mouse listeriosis model. J Immunol. 1999;163(5):2777–82. 10453021.
53. Sun CM, Deriaud E, Leclerc C, Lo-Man R, Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity. 2005;22(4):467–77. 15845451.
54. Dai WJ, Kohler G, Brombacher F, Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol. 1997;158(5):2259–67. 9036973.
55. Franchini M, Abril C, Schwerdel C, Ruedl C, Ackermann M, Suter M, Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus. J Virol. 2001;75(1):83–9. 11119576.
56. Regner M, Martinez X, Belnoue E, Sun CM, Boisgerault F, Lambert PH, et al. Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres. J Immunol. 2004;173(4):2669–74. 15294984.
57. Siegrist CA, Saddallah F, Tougne C, Martinez X, Kovarik J, Lambert PH, Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?Vaccine. 1998;16(14–15):1473–8. 9711791.
58. Sancho D, Mourao-Sa D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest. 2008;118(6):2098–110. 18497879. doi: 10.1172/JCI34584
59. Lahoud MH, Ahmet F, Kitsoulis S, Wan SS, Vremec D, Lee CN, et al. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J Immunol. 2011;187(2):842–50. 21677141. doi: 10.4049/jimmunol.1101176
60. Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, Shen H, Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol. 2002;168(4):1528–32. 11823476.